NotGenentech

DYODD.

[NotGenentech @NotGenentech]

@oakazaki Resveratrol.

[NotGenentech @NotGenentech]

@jeromeleonard5 Hilarious. Sac-TMT also had plenty of cytopenias and dose interruptions. Let's see their non-China data.

[NotGenentech @NotGenentech]

@FordePatrick Because PD1/chemo has no safety concerns?

[Bishal Gyawali, MD, PhD, FASCO @oncology_bg]

The most important paper of #ASCO26 just dropped in Nature Med! Or any other @asco or @myESMO meetings to be honest. When you hear someone present “the toxicities were acceptable”, please respond “downplaying toxicities is not acceptable”. Thank you @NatureMedicine for publishing this piece.

https://t.co/ydAfoTWVJ0

[NotGenentech @NotGenentech]

@jeromeleonard5 @LaurenByersMD @ASCO @NatureMedicine @SclcSMASHERS @LUNGevity @UTMDAnderson Unlikely.

[NotGenentech @NotGenentech]

@jeromeleonard5 @LaurenByersMD @ASCO @NatureMedicine @SclcSMASHERS @LUNGevity @UTMDAnderson There is no meaningful differentiation.

[NotGenentech @NotGenentech]

@jeromeleonard5 @LaurenByersMD @ASCO @NatureMedicine @SclcSMASHERS @LUNGevity @UTMDAnderson That's just Top1i ADCs for ya

[NotGenentech @NotGenentech]

@LifeSciVC Tone deaf.

[NotGenentech @NotGenentech]

@drrichjlaw @jrkelly The speed of enrollment is unparalleled. We can have go/no-go decisions from phase I data at a fraction of the time and money spent ex-China.

[NotGenentech @NotGenentech]

@pharmabro0782 @jrkelly @DueDoctor R&D is cheaper and faster in China. Biotech will be dead soon in the west (USA+Europe) without significant protective measures.

[NotGenentech @NotGenentech]

@varma_ashwin97 Eikon is a failed company. They have extracted nothing from their initial thesis of SMT for drug discovery despite millions raised&spent. All of their clinical stage assets are in-licensed (TLR7/8, PARP1i) or targets that no one cares about anymore (WRNi).

[NotGenentech @NotGenentech]

@DraMartinezLago @OncoAlert @GrupoGetne @ASCO @myESMO @Ja_Capdevila @JHernando3 @Alej_GarciaMD This is a biparatopic TCE. Not a ADC.

[NotGenentech @NotGenentech]

@venkmurthy Please focus on cardiology and not oncology.

[NotGenentech @NotGenentech]

@DrPaulyDeSantis Material event. 😋

[NotGenentech @NotGenentech]

@gerlach_d Church of Scientology did Duggan a "favor".

[NotGenentech @NotGenentech]

@oncology_bg MFS is not an accepted endpoint in prostate cancer.

[NotGenentech @NotGenentech]

@aditharun_ Darax is very active on G12D/V.

[NotGenentech @NotGenentech]

@RayWangonc @allisonoconn @PTarantinoMD Anti-EGFR (mAb or TKI) and Daraxonrasib have overlapping tox profile.